Aequs IPO

Aequs Limited's IPO introduces a player in the precise aerospace components sector, with an eye on lucrative defense opportunities. While its vertically integrated operations across global facilities offer a competitive edge, a closer look at its financials reveals challenges. Revenues have seen mixed growth, but the company remains loss-making with negative cash flows, as expenses climb faster than sales. This contrasts sharply with peers like Azad Engineering, which boasts significantly healthier operating margins and profitability. The IPO, priced at ₹124, aims to raise ₹921 crore, mostly for debt repayment and expansion, with promoters maintaining a strong stake. Despite an implied post-infusion price-to-book around 5-6x, which still feels steep given the current performance, short-term listing gains seem plausible, supported by a strong grey market premium and reputable underwriters. However, the path to sustained profitability for long-term investors appears less clear. Opinion: For investors eyeing quick profits, listing gains might materialize due to market buzz. However, those seeking long-term value should proceed cautiously. Aequs' current financial health – persistent losses and weak cash flows – needs significant improvement before it can truly justify its valuation as a sound, long-term fundamental play.